Rapid characterization of spike variants via mammalian cell surface display.
Rapid characterization of spike variants via mammalian cell surface display.
复制标题
通过哺乳动物细胞表面显示快速表征尖峰变异。
DOI:
10.1016/j.molcel.2021.11.024
复制
发表时间:
2021-12-16
期刊:
影响因子:
16
通讯作者:
Finkelstein IJ
中科院分区:
文献类型:
--
作者:
Javanmardi K;Chou CW;Terrace CI;Annapareddy A;Kaoud TS;Guo Q;Lutgens J;Zorkic H;Horton AP;Gardner EC;Nguyen G;Boutz DR;Goike J;Voss WN;Kuo HC;Dalby KN;Gollihar JD;Finkelstein IJ
The SARS-CoV-2 spike protein is a critical component of vaccines and a target for neutralizing monoclonal antibodies (nAbs). Spike is also undergoing immunogenic selection with variants that increase infectivity and partially escape convalescent plasma. Here, we describe Spike Display, a high-throughput platform to rapidly characterize glycosylated spike ectodomains across multiple coronavirus-family proteins. We assayed ∼200 variant SARS-CoV-2 spikes for their expression, ACE2 binding, and recognition by 13 nAbs. An alanine scan of all five N-terminal domain (NTD) loops highlights a public epitope in the N1, N3, and N5 loops recognized by most NTD-binding nAbs. NTD mutations in variants of concern B.1.1.7 (alpha), B.1.351 (beta), B.1.1.28 (gamma), B.1.427/B.1.429 (epsilon), and B.1.617.2 (delta) impact spike expression and escape most NTD-targeting nAbs. Finally, B.1.351 and B.1.1.28 completely escape a potent ACE2 mimic. We anticipate that Spike Display will accelerate antigen design, deep scanning mutagenesis, and antibody epitope mapping for SARS-CoV-2 and other emerging viral threats. Spike Display accelerates genotype-to-phenotype studies of SARS-CoV-2 spike protein N-terminal domain loops N1, N3, and N5 form a public epitope for neutralizing antibodies Variants of concern escape several classes of NTD-targeting neutralizing antibodies An ACE2 peptide mimic has lost potency against several broadly circulating variants The SARS-CoV-2 spike protein is a critical target of the immune system. Javanmardi et al. report a mammalian cell display platform for rapidly screening the antigenicity and ACE2 affinity of spike variants. This platform, termed Spike Display, accelerates antigen design and antibody epitope mapping for viral glycoproteins.
登录
查看更多内容
影响因子:
16.6
作者:
Greaney AJ;Starr TN;Barnes CO;Weisblum Y;Schmidt F;Caskey M;Gaebler C;Cho A;Agudelo M;Finkin S;Wang Z;Poston D;Muecksch F;Hatziioannou T;Bieniasz PD;Robbiani DF;Nussenzweig MC;Bjorkman PJ;Bloom JD
通讯作者:
Bloom JD
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
影响因子:
64.5
作者:
Hoffmann M;Arora P;Groß R;Seidel A;Hörnich BF;Hahn AS;Krüger N;Graichen L;Hofmann-Winkler H;Kempf A;Winkler MS;Schulz S;Jäck HM;Jahrsdörfer B;Schrezenmeier H;Müller M;Kleger A;Münch J;Pöhlmann S
通讯作者:
Pöhlmann S
影响因子:
56.9
作者:
Hamilton, SR;Bobrowicz, P;Gerngross, TU
通讯作者:
Gerngross, TU
影响因子:
3
作者:
Daily J
通讯作者:
Daily J